BioIVT Acquires Cypex, a Leading Manufacturer of Drug-metabolizing Enzymes

Cypex’s recombinant xenobiotic metabolizing enzymes complement BioIVT’s extensive portfolio of hepatocytes and related hepatic products for drug research and development.

European pharma needs to keep manufacturing on the continent and become more digitised to stay competitive, say speakers at new event

The newly announced agenda for Connect in Pharma focuses on innovation as the foundation of a strong pharmaceutical industry in Europe. In order to ensure a strong future for European pharma, businesses need to prioritise digitalisation and maintain control of production lines, say two speakers due to present at the Geneva-based event in September.

Service Portfolio Expanded for Drug Delivery Research

Antibiotic Research UK Announces New CEO

The charity Antibiotic Research UK welcomes Jonathan Pearce as the new CEO, effective 1 August 2022. He takes over the position from founder Professor Colin Garner, who retired at the end of July 2022.

Trace Metal Analysis: An Established Technique Driving Advances in Alternative Energy Materials

Peptides for Diabetes Research—a Special Offer of BOC Sciences

BOC Sciences has been constantly enriching its peptide product library for years. Its peptides for diabetes research are recently brought into focus due to the growing concerns on this problem.

Stable and Quality Supply of Phosphoramidites Is a Reality at BOC Sciences

As an expert in chemistry, BOC Sciences understands how important the quality of phosphoramidite is to successful oligo synthesis and remarkably, it has taken concrete actions to manufacture certified products.

BOC Sciences Shares Its Strategic Emphasis on NTPs during the Pandemic

"Whether your studies involve DNA sequencing, cDNA synthesis, RT-PCR, RCA, MDA, DNA labeling, in vitro transcription, siRNA synthesis, or RNA amplification, we stock hundreds of modified or natural NTPs to suit your various molecular biological applications," a BOC Sciences manager announces to the public.

Vaxess Announces Launch of Phase 1 Trial For H1 Influenza Vaccine Patch

Company focused on creating shot-free future of vaccines; first human trial of Vaxess MIMIX™ vaccine patch will focus on administering influenza vaccine

Lyniate Merges with CareCom, Further Extending Capabilities of Interoperability Leader

Creative Biogene Launches Zebrafish Disease Models to Support Drug Discovery and Toxicology Research

IntegrateRNA Launches GalNAc-Oligonucleotide Conjugation Service to Support Oligonucleotides Therapeutic Research

MicroRNA Agomir Synthesis: Supporting New Drug Research with Cutting-Edge Chemical Synthesis Technology

Creative Bioarray Offers Clonality Analysis Service to Accelerate Biopharmaceutical or Biosimilar Development

Creative Bioarray Develops Full-service Support for Transgene Mapping

Creative Bioarray Has Developed Cell Immortalization Services to Support Potential Drug Development

GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine

GreenLight Biosciences and Samsung Biologics announce successful completion of the first commercial-scale engineering run for the companies' mRNA production partnership

Creative Peptides Delivers Phage Display Services with Versatile Peptide Library

Creative Peptides delivers phage display services with a versatile phage peptide library, hoping to assist researchers in jumpstarting peptide drug screening.

BioIVT Announces Promotion of Dr. Richard Haigh to CEO

BioIVT, a leading global provider of biospecimens, cell and gene therapy related products, and research models and services for drug development purposes, announced the promotion of Richard Haigh, PhD, from Chief Operating Officer to Chief Executive Officer effective August 1.

Creative Biogene Released Complete C. elegans Cell Isolation and Culture Services

Creative Biogene released complete C. elegans cell isolation and culture services with high-quality data delivery, as well as in-depth scientific and technical support